Abstract: Disclosed herein are isolated polypeptides and antibodies with improved sensitivity and decreased background signals and methods of using the same. Specifically, the antibodies comprise polypeptides comprising a sequence-defined CH2 domain linked to hinge domain.
| # | Name | Date |
|---|---|---|
| 1 | 202547128876-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [18-12-2025(online)].pdf | 2025-12-18 |
| 2 | 202547128876-STATEMENT OF UNDERTAKING (FORM 3) [18-12-2025(online)].pdf | 2025-12-18 |
| 4 | 202547128876-Sequence Listing in PDF [18-12-2025(online)].pdf | 2025-12-18 |
| 5 | 202547128876-PROOF OF RIGHT [18-12-2025(online)].pdf | 2025-12-18 |
| 6 | 202547128876-PRIORITY DOCUMENTS [18-12-2025(online)].pdf | 2025-12-18 |
| 7 | 202547128876-POWER OF AUTHORITY [18-12-2025(online)].pdf | 2025-12-18 |
| 8 | 202547128876-FORM 1 [18-12-2025(online)].pdf | 2025-12-18 |
| 9 | 202547128876-DRAWINGS [18-12-2025(online)].pdf | 2025-12-18 |
| 10 | 202547128876-DECLARATION OF INVENTORSHIP (FORM 5) [18-12-2025(online)].pdf | 2025-12-18 |
| 11 | 202547128876-COMPLETE SPECIFICATION [18-12-2025(online)].pdf | 2025-12-18 |